drugset / Trial / NCT05669963

Role of Oral Lactoferrin in Prevention of Recurnt Bacterial Vaginosis in Pregnancy

NCT05669963

Phase 2/3 Unknown 66 enrolled Zagazig University
RandomizedParallel-groupOpen-labelTreatment

Summary

lactoferrin is believed to modulate immunity and help in prevention of recurrent bacterial vaginosis.In this study, the role of lactoferrin is assessed during third trimester of pregnancy.

Timeline

Start
2022-07-01
Primary completion
2023-01
Completion
2023-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lactoferrin Protein / enzyme biologic 1 unknown Oral

Indications